Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07513298

Structured Wii Aerobic Protocol on Reaction Time and Pulmonary Functions in Over Weight School- Aged Children

Childhood overweight have emerged as major global health concerns and are linked to lower pulmonary functions and reaction time levels among school-aged children. Although exercise, particularly multicomponent training, effectively improves pulmonary functions, maintaining exercise adherence in children with overweight remains a significant challenge. As a result, there is a need for more engaging and motivating exercise options for this group, and active structured wii protocol, which involve full-body movement and boost energy expenditure, have been suggested as a promising alternative..

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Over Weight School Age Children

Age range

10 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Outpatient Clinics of Universities and Private Medical Centers in Cairo

Cairo, 11571, Egypt

Location status: Recruiting

Location contact

Mohamed Zidan

CONTACT

[email protected]

01016469801

About this study

Wii Fit aerobic training produces effects similar to standard rehabilitation treatments and requires low energy. This shows that it may be an effective rehabilitation technique for adults and older people with low energy levels. A review found that video games are safe and practicable in children with lung is sues. The principle of this training is that aerobic exercise en hances pulmonary adaptation by increasing the strength and endurance of the respiratory muscles. Altered aerobic training due to endurance training might diminish smooth muscle tone in the airways and enhance expiratory flow. Regular lung stretching caused by airway smooth muscle diminishes airway resistance during aerobic exercise. Reduced tone and smooth muscle contraction may reduce air resistance. As smooth mus cle tone diminishes, airway resistance decreases, and lung vol ume falls, these mechanisms are anticipated to enhance airflow

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • School age children 10-15 years.
  • Both gender.
  • Diagnosed with over weight with Body mass index (BMI) is at or above the 85th percentile but less than 95th percentile for age , gender and height.
  • All participants and parents/guardians were familiar with possible risks associated with the experimental procedures and signed a consent form to participate in the study.

Exclusion criteria

  • Dysfunction restricting activity, such as neurological disorders.
  • Pulmonary disorders such as COPD and malignancy.
  • Unstable vital signs.
  • Orthopedic problems such as scoliosis and kyphosis.
  • Visual and hearing impairments.
  • Brain injury

Treatment and study plan

The Nintendo Wii Fit operates on the Wii system, produced by Nintendo Co., Ltd, based in Kyoto, Japan.

Device

The Nintendo Wii Fit operates on the Wii system, produced by Nintendo Co., Ltd, based in Kyoto, Japan. Among its features is a collection of interactive video games that require players to embody their on-screen character using a compact, wireless controller capable of motion detection.

Chest physical therapy and diet therapy

Other

Chest Physiotherapy:

Breathing exercises (diaphragmatic breathing, segmental breathing) Incentive spirometry (if applicable) Thoracic expansion exercises

Diet therapy :

Individualized calorie-controlled diet plan

Primary outcomes

  1. Forced vital capacity (FVC)

    Time frame: pre and post 36 sessions ( 3 sessions/week ) for 3 months

    The maximum amount of air expired after the maximum Inspiration in liters.

  2. Forced expiratory volume in 1 s (FEV1)

    Time frame: Pre and post 36 sessions ( 3 sessions/week) for 3 months

    The air volume expired in the first second after maximal Inspiration in liters.

  3. Peak expiratory flow (PEF)

    Time frame: Pre and post 36 sessions ( 3 sessions /week ) for 3 months

    Achieving maximum forced expiration without hesitation from the point of peak lung inflation yields the maximum expiratory flow

Secondary outcomes

  1. Chest Expansion

    Time frame: Pre and post 36 sessions ( 3 sessions / week ) for 3 months

    Upper chest expansion (2nd intercostal space) & Lower chest expansion (xiphoid) were assessed from the reference point mentioned by using tab

Other outcomes

  1. 6-Minute Walk Test (6-MWT) ( To measure Functional Capacity )

    Time frame: Pre and post 36 sessions ( 3 sessions / week ) for 3 months

    The children's submaximal functional capacity was evaluated by measuring the maximum distance they could walk in 6 min

  2. Timed Up and Go test (TUG) ( To measure Functional Capacity )

    Time frame: Pre and post 36 sessions ( 3 sessions / week ) for 3 months

    This straightforward evaluation of a child's mobility includes static and dynamic balancing measures .It considers how long it takes for an individual to stand up from a chair, walk 3 m, turn around, and then sit back down

  3. Ruler Drop Test ( To measure reaction time )

    Time frame: pre and post 36 sessions ( 3 sessions / week ) for 3 months

    The Ruler Drop Test is a simple clinical method used to assess reaction time. A ruler is held vertically between the participant's thumb and index finger without contact. The examiner releases the ruler unexpectedly, and the participant attempts to catch it as quickly as possible

  4. Human Benchmark Reaction Time Test ( To measure reaction time )

    Time frame: pre and post 36 sessions ( 3 sessions / week ) for 3 months

    The Human Benchmark Reaction Time Test is a computerized assessment that measures visual reaction time. Participants are instructed to click (or tap) the screen as quickly as possible when a visual stimulus changes color (typically from red to green). The reaction time is automatically recorded in milliseconds.

Sponsors and collaborators

Lead sponsor

Al-Zaytoonah University of Jordan

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 7, 2026
Registry last updated
Apr 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.